Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
With speculation online about OpenAI having reached the AGI stage of ChatGPT development, Sam Altman says that's not what's ...
More orders are expected Tuesday amid fallout from his first moves, including his issuing pardons for more than a thousand ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Their mutual friction goes back to the foundational ideals of OpenAI. But now both seem to have Trump’s favour: Elon Musk as ...
OpenAI has recently released its first AI agent, Operator. But how is it different from the ChatGPT platform? Let's find out.
Hatred now has a home in the Oval Office - and the US President's entirely pliant Cabinet will be under constant pressure to ...